Drawing for Serial No. 87268455

USPTO serial 87268455

Serial No. 87268455

Reviewed by CopyMark Law Group

Status 606
Filing date
Status date
Registration date
—
Examiner
DUBIN, DAVID I
Law office
INTENT TO USE SECTION

What this means

This page summarizes the public USPTO record for this serial number, including owners, goods and services, and prosecution history.

Need help with Serial No. 87268455?

If you own this trademark, we can monitor new filings and help with USPTO deadlines. If you do not, we can file a new U.S. application.

Current trademark owner
Monitor this mark, or talk with CopyMark about this registration.
Not the owner?
File a new U.S. trademark application, or speak with our attorneys.

Owner

Attorney of record

The USPTO lists this attorney as the applicant's representative for correspondence on this application.

Tony Zhang

TONY ZHANG FISH & RICHARDSON P.C.P.O. BOX 1022MINNEAPOLIS, MN 55440-1022UNITED STATES

Goods and services

ClassDescriptionStatusFirst use
005Human vaccine preparations; anti-cancer agent, namely, anti-cancer preparations; human pharmaceutical product, namely, pharmaceutical preparations for the treatment of infectious diseases and cancer; western medicine in the nature of prescription and non-prescription medicines, namely, pills, tablets, capsules, caplets, liquid drops, sachets, medical solutions, and pharmaceutical preparations for the treatment of infectious diseases and cancer; western medicine raw material, namely, herbs for medicinal purposes; human use pharmaceutical, namely, pharmaceutical products for the prevention and treatment of cancer; topical ointment, namely, antibiotic ointments; anti-inflammatory analgesic; medical and biological agents, namely, diagnostic agents, preparations and substances for medical purposes; dermatological agents, namely, diagnostic agents, preparations and substances for medical purposes; medical chemical agents, namely, diagnostic agents, preparations and substances for medical purposes; chemical agents, namely, diagnostic agents, preparations and substances for medical purposes; medical adjuvants; medicinal chemical formulation in the nature of chemical preparations for medical purposes, namely, for infectious diseases and cancer; pharmaceutical products for the prevention and treatment of infectious diseases and cancer; pharmaceutical agents, namely, drug delivery agents in the form of coatings for tablets that facilitate the delivery of pharmaceutical preparations; animal use pharmaceutical product, namely, pharmaceutical preparations for animal skincare; animal use detergents, namely, germicidal detergents; veterinary chemical formulation, namely, chemical preparations for sanitary purposes; veterinary agents, namely, drug delivery agents in the form of coatings for tablets that facilitate the delivery of pharmaceutical preparations; veterinary biological agents, namely, drug delivery agents in the form of coatings for tablets that facilitate the delivery of pharmaceutical preparations; veterinary drugs, namely, nutritional supplements and pharmaceutical products for treating infectious diseases and cancer for pets; veterinary pharmaceutical agents, namely, drug delivery agents consisting of compounds that facilitate delivery of a wide range of pharmaceuticalsACTIVE—
035Wholesale and retail store services featuring chemical products, western medicine, pet supplies, animal drugs, and veterinary drugsACTIVE—
044Medical services; distance medical services, namely, medical services; therapeutic radiological services; hospital services; medical clinic services; traditional Chinese medicine, namely, holistic health services featuring herbal medicine; folk medical therapy, namely, holistic health services featuring herbal medicine; alternative therapy services, namely, alternative medicine services; spinal massage therapy; various pathology test, namely, medical diagnostic testing, monitoring and reporting services; biochemical test, namely, medical diagnostic testing, monitoring and reporting services; pharmaceutical dispenser, namely, dispensing of pharmaceuticals; medical consultancy; sanatorium service; palliative care services; nursing home service; physiotherapy; midwife service; medical assistance; health care; home health care services; artificial insemination services; in vitro fertilization services; health consultation; health center service, namely, urgent medical care centers; medical advice for individuals with disabilities; medical cosmetology services; medical cosmetic service, namely, non-permanent hair removal; rental of medical machines and apparatus; medical equipment rental; food nutrition consultation; animal beauty, namely, animal grooming; pet grooming; consultation services in the field of animal beauty in the nature of animal grooming; animal husbandry consultation; animal breeding; animal health service, namely, veterinary services; veterinary services; veterinary assistance in the nature of veterinary services; pet chip seeding services, namely, implanting subcutaneous microchips into pets for purposes of tracking and identification; aquaculture services, namely, the cultivation and breeding of plants or animals in a water environmentACTIVE—

Related trademarks

CopyMark links this record to cited §2(d) serials, the owner's other marks, Nice classes, similar mark names, and recently changed USPTO applications.

Prosecution history

Latest event (MAB6): The intent-to-use application was abandoned because no acceptable Statement of Use (or valid extension) was filed before the Notice of Allowance deadline expired. The application is dead unless revived within a limited window.

DateCodeEventWhat it means
Feb 19, 2019MAB6ABANDONMENT NOTICE E-MAILED - NO USE STATEMENT FILEDThe intent-to-use application was abandoned because no acceptable Statement of Use (or valid extension) was filed before the Notice of Allowance deadline expired. The application is dead unless revived within a limited window.
Feb 18, 2019ABN6ABANDONMENT - NO USE STATEMENT FILEDThe intent-to-use application was abandoned because no acceptable Statement of Use (or valid extension) was filed before the Notice of Allowance deadline expired. The application is dead unless revived within a limited window.
Jul 14, 2018EXRANOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED—
Jul 12, 2018EX2GSOU EXTENSION 2 GRANTED—
Jul 12, 2018EXT2SOU EXTENSION 2 FILED—
Jul 12, 2018EEXTSOU TEAS EXTENSION RECEIVEDThe applicant requested more time to file a Statement of Use before the Notice of Allowance deadline. Each extension typically adds six months. A limited number of extensions are available for intent-to-use applications not yet in use.
Jan 5, 2018EXRANOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED—
Jan 3, 2018EX1GSOU EXTENSION 1 GRANTED—
Jan 3, 2018EXT1SOU EXTENSION 1 FILED—
Jan 3, 2018EEXTSOU TEAS EXTENSION RECEIVEDThe applicant requested more time to file a Statement of Use before the Notice of Allowance deadline. Each extension typically adds six months. A limited number of extensions are available for intent-to-use applications not yet in use.
Jan 3, 2018TCCATEAS CHANGE OF CORRESPONDENCE RECEIVED—
Jul 18, 2017NOAMNOA E-MAILED - SOU REQUIRED FROM APPLICANTA Notice of Allowance means your intent-to-use application cleared examination and opposition but is not registered yet. You must file a Statement of Use showing the mark in commerce, or request an extension, before the deadline — usually six months from the notice date.
May 23, 2017NPUBOFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED—
May 23, 2017PUBOPUBLISHED FOR OPPOSITIONYour mark was published in the USPTO Official Gazette for a 30-day opposition window. During that period, third parties who believe they would be harmed can file an opposition. If no opposition is filed, prosecution usually continues toward registration or a Notice of Allowance.
May 3, 2017NONPNOTIFICATION OF NOTICE OF PUBLICATION E-MAILED—
Apr 13, 2017CNSAAPPROVED FOR PUB - PRINCIPAL REGISTER—
Apr 13, 2017XAECEXAMINER'S AMENDMENT ENTERED—
Apr 13, 2017GNENNOTIFICATION OF EXAMINERS AMENDMENT E-MAILED—
Apr 13, 2017GNEAEXAMINERS AMENDMENT E-MAILED—
Apr 13, 2017CNEAEXAMINERS AMENDMENT -WRITTEN—
Mar 20, 2017XAECEXAMINER'S AMENDMENT ENTERED—
Mar 20, 2017GNENNOTIFICATION OF EXAMINERS AMENDMENT E-MAILED—
Mar 20, 2017GNEAEXAMINERS AMENDMENT E-MAILED—
Mar 20, 2017CNEAEXAMINERS AMENDMENT -WRITTEN—
Mar 16, 2017DOCKASSIGNED TO EXAMINER—
Dec 21, 2016MDSCNOTICE OF DESIGN SEARCH CODE E-MAILED—
Dec 20, 2016NWOSNEW APPLICATION OFFICE SUPPLIED DATA ENTERED—
Dec 17, 2016NWAPNEW APPLICATION ENTERED—

Frequently asked questions

Related guidance